144: Filer Information

Filer CIK

0001547134

Filer CCC

XXXXXXXX

Is this a LIVE or TEST Filing?

LIVE

TEST

Submission Contact Information

Name

Phone

E-Mail Address

144: Issuer Information

Name of Issuer

Cellebrite DI Ltd.

SEC File Number

001-40772

Address of Issuer

94 SHLOMO SHMELZER ROAD
PETAH TIKVA
ISRAEL
4970602

Phone

972-73-394-8000

Name of Person for Whose Account the Securities are To Be Sold

DAVID GEE

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

OFFICER

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

Ordinary shares, par value NIS 0.00001

Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
38th Floor
New York � NY � 10004

2243

30056.20

250128541

05/21/2026

Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

Ordinary shares, par value NIS 0.00001

05/20/2026

Restricted Share Units Vested Under an Issuer S-8 Registered Plan

Cellebrite DI Ltd.

5673

05/20/2026

Employee compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds

David Gee
94 Shlomo Shmelzer Road
Petah Tikva � L3 � 4970602

Ordinary shares, par value NIS 0.00001

02/23/2026

2609

32514.59

David Gee
94 Shlomo Shmelzer Road
Petah Tikva � L3 � 4970602

Ordinary shares, par value NIS 0.00001

02/24/2026

4517

53932.98

David Gee
94 Shlomo Shmelzer Road
Petah Tikva � L3 � 4970602

Ordinary shares, par value NIS 0.00001

05/12/2026

228

2996.58

144: Remarks and Signature

Remarks

The reporting person sold the securities reported herein on 05/21/2026 pursuant to a mandatory, non-discretionary, sell-to-cover arrangement for the purposes of satisfying income tax liabilities incurred upon vesting of restricted share unit awards only.

Date of Notice

05/21/2026

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ David Gee

144: Filer Information

Submission Contact Information

144: Issuer Information

144: Securities Information

144: Securities To Be Sold

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

ATTENTION:

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

SEC Form 144 filed by Cellebrite DI Ltd.